Pattern of use, safety and tolerability of the diagnostic agent NeuraCeqTM in European clinical practice: A cross-sectional, retrospective, non-interventional post-authorisation safety study (PASS) (FBB-01_03_13)

16/06/2016
10/03/2021
EU PAS number:
EUPAS13366
Study
Finalised
Documents
Study protocol
Study results
Study report
Other information